Actinic Keratosis Market Ready to Surpass US$ 11,628.0 Mn by 2030

 

Actinic Keratosis Market

Actinic keratosis (AK) is a common skin condition that is characterized by rough, scaly patches or lesions that develop on the skin that is exposed to the sun. AK is considered a precancerous condition, as it can progress to squamous cell carcinoma if left untreated. The actinic keratosis market has been on the rise in recent years, and there are several factors contributing to this growth.

Global Actinic Keratosis Market is estimated to be valued at US$ 8,070.0 Mn in 2022 and expected to exhibit a CAGR of 4.7% over the forecast period (2022-2030).

One of the primary drivers of the Actinic Keratosis Market is the aging population. As people age, their skin becomes thinner and less able to protect itself from the sun's damaging rays. This makes older adults more susceptible to developing actinic keratoses. According to the American Academy of Dermatology, approximately 40% of people over the age of 40 will develop at least one actinic keratosis in their lifetime.

Another factor contributing to the growth of the Actinic Keratosis Market is increased awareness and diagnosis. As more people become aware of the condition and its potential to progress to skin cancer, they are seeking medical attention and diagnosis. Dermatologists are also becoming more skilled at identifying actinic keratoses, which has led to more accurate diagnoses and treatment.

Skin cancer is one of the most common types of cancer in the United States, and the incidence of skin cancer is on the rise. This has led to increased awareness of the importance of protecting the skin from the sun's damaging rays and seeking medical attention for suspicious skin lesions. Actinic keratosis is considered a precursor to squamous cell carcinoma, one of the most common types of skin cancer. As such, the rising incidence of skin cancer has also led to increased diagnosis and treatment of actinic keratoses.

Bausch Health Companies Inc., Perrigo Company plc., Sun Pharmaceutical Industries Ltd., Hill Dermaceuticals, Inc., Spear Pharmaceuticals, Tolmar Pharmaceuticals, Inc., Bioforntera AG, Cypher Pharmaceuticals Inc., Vidac, Athenex, Inc., 3M, and Mayne Pharma Group Limited are among the companies involved.

Comments

Popular posts from this blog

Ginseng Market Outlook, Analysis and forecast up to 2028

Forging has significant application in creation of various metal for wide range of applications

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19